86 related articles for article (PubMed ID: 12484050)
1. [High concentration of E-cadherin in portal drainage vein of colorectal cancer patients may predict metachronous liver metastasis].
Ohue M; Takahashi K; Yamaguchi T; Murata Y; Tanaka S; Umekita N; Mori T
Gan To Kagaku Ryoho; 2002 Nov; 29(12):2263-6. PubMed ID: 12484050
[TBL] [Abstract][Full Text] [Related]
2. Circulating transforming growth factor beta 1 as a predictor of liver metastasis after resection in colorectal cancer.
Tsushima H; Ito N; Tamura S; Matsuda Y; Inada M; Yabuuchi I; Imai Y; Nagashima R; Misawa H; Takeda H; Matsuzawa Y; Kawata S
Clin Cancer Res; 2001 May; 7(5):1258-62. PubMed ID: 11350892
[TBL] [Abstract][Full Text] [Related]
3. Elevated IL-8 levels in the drainage vein of resectable Dukes' C colorectal cancer indicate high risk for developing hepatic metastasis.
Haraguchi M; Komuta K; Akashi A; Matsuzaki S; Furui J; Kanematsu T
Oncol Rep; 2002; 9(1):159-65. PubMed ID: 11748475
[TBL] [Abstract][Full Text] [Related]
4. Early prediction of tumor recurrence after curative resection of gastric carcinoma by measuring soluble E-cadherin.
Chan AO; Chu KM; Lam SK; Cheung KL; Law S; Kwok KF; Wong WM; Yuen MF; Wong BC
Cancer; 2005 Aug; 104(4):740-6. PubMed ID: 15991243
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of serum soluble E-cadherin in colorectal carcinoma.
Okugawa Y; Toiyama Y; Inoue Y; Iwata T; Fujikawa H; Saigusa S; Konishi N; Tanaka K; Uchida K; Kusunoki M
J Surg Res; 2012 Jun; 175(2):e67-73. PubMed ID: 22277332
[TBL] [Abstract][Full Text] [Related]
6. Predicting metachronous liver metastasis from colorectal cancer using serum proteomic fingerprinting.
Zhu D; Zhong Y; Wu H; Ye L; Wang J; Li Y; Wei Y; Ren L; Xu B; Xu J; Qin X
J Surg Res; 2013 Oct; 184(2):861-6. PubMed ID: 23721930
[TBL] [Abstract][Full Text] [Related]
7. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
8. Significance of the serum level of soluble E-cadherin in patients with HCC.
Soyama A; Eguchi S; Takatsuki M; Kawashita Y; Hidaka M; Tokai H; Nagayoshi S; Mochizuki S; Matsumoto S; Hamasaki K; Tajima Y; Kanematsu T
Hepatogastroenterology; 2008; 55(85):1390-3. PubMed ID: 18795696
[TBL] [Abstract][Full Text] [Related]
9. Biliary carcinoembryonic antigen levels can predict metachronous liver metastasis of colorectal cancer.
Ishida H; Yoshinaga K; Gonda T; Ando M; Hojo I; Fukunari H; Iwama T; Mishima Y
Anticancer Res; 2000; 20(1B):523-6. PubMed ID: 10769718
[TBL] [Abstract][Full Text] [Related]
10. Predictive molecular markers for colorectal cancer patients with resected liver metastasis and adjuvant chemotherapy.
Lassmann S; Tang L; Capanu M; Brabletz T; Schöpflin A; Zur Hausen A; Gonen M; Kemeny N; Shia J; Klimstra D; Werner M
Gastroenterology; 2007 Dec; 133(6):1831-9. PubMed ID: 18054556
[TBL] [Abstract][Full Text] [Related]
11. Soluble CXCL16 in preoperative serum is a novel prognostic marker and predicts recurrence of liver metastases in colorectal cancer patients.
Matsushita K; Toiyama Y; Tanaka K; Saigusa S; Hiro J; Uchida K; Inoue Y; Kusunoki M
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S518-27. PubMed ID: 21845497
[TBL] [Abstract][Full Text] [Related]
12. [The detection and its clinical significance of cancer cells in portal vein blood of patients with colorectal carcinoma].
Luo C; Li S
Zhonghua Wai Ke Za Zhi; 1999 Apr; 37(4):214-5. PubMed ID: 11829822
[TBL] [Abstract][Full Text] [Related]
13. Liver metastasis of colorectal cancer by protein-tyrosine phosphatase type 4A, 3 (PRL-3) is mediated through lymph node metastasis and elevated serum tumor markers such as CEA and CA19-9.
Hatate K; Yamashita K; Hirai K; Kumamoto H; Sato T; Ozawa H; Nakamura T; Onozato W; Kokuba Y; Ihara A; Watanabe M
Oncol Rep; 2008 Oct; 20(4):737-43. PubMed ID: 18813812
[TBL] [Abstract][Full Text] [Related]
14. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.
Oberg A; Höyhtyä M; Tavelin B; Stenling R; Lindmark G
Anticancer Res; 2000; 20(2B):1085-91. PubMed ID: 10810401
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of soluble E-selectin in colorectal cancer.
Uner A; Akcali Z; Unsal D
Neoplasma; 2004; 51(4):269-74. PubMed ID: 15254658
[TBL] [Abstract][Full Text] [Related]
16. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant hepatic arterial infusion chemotherapy after curative resection for Dukes C colorectal cancer: a pilot study.
Ota M; Shimada H; Masui H; Tanaka K; Yamaguchi S; Ichikawa Y; Togo S; Ike H; Oki S
Hepatogastroenterology; 2004; 51(55):124-7. PubMed ID: 15011846
[TBL] [Abstract][Full Text] [Related]
18. [Application of SELDI-TOF-MS in detection of liver metastasis from colorectal cancer].
Shi YJ; Zhao Y; Xu JM; Lai YH; Yu XZ; Zhong YS; Wei Y; Ren L; Zhu DX; Liu YK; Niu WX; Qin XY
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):910-3. PubMed ID: 19173991
[TBL] [Abstract][Full Text] [Related]
19. Metachronous liver metastasis of colorectal cancer: timing of occurrence and efficacy of adjuvant portal chemotherapy.
Kimura T; Akazai Y; Iwagaki H; Nonaka Y; Ariki N; Fuchimoto S; Hizuta A; Tanaka N; Orita K
Anticancer Res; 1995; 15(4):1585-8. PubMed ID: 7654051
[TBL] [Abstract][Full Text] [Related]
20. Serum CD10 is associated with liver metastasis in colorectal cancer.
Sasaki T; Kuniyasu H; Luo Y; Fujiwara R; Kitayoshi M; Tanabe E; Kato D; Shinya S; Fujii K; Ohmori H; Yamashita Y
J Surg Res; 2014 Dec; 192(2):390-4. PubMed ID: 24972738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
